Compartmental Modelling of ICG Pharmacokimetrics for Breast Tumors
This paper investigates the pharmacokinetics of the optical contrast agent indocyanine green (ICG) as a malignancy indicator for breast cancer. Several authors have conducted optical measurements using Indocyanine green (ICG) in animal models (Colacino, Cuccia, Gurfinkel) and human patients (Colacin...
Published: |
|
---|---|
Online Access: | http://hdl.handle.net/2047/d10008263 |
Similar Items
-
Cetuximab-modified silica nanoparticle loaded with ICG for tumor-targeted combinational therapy of breast cancer
by: Xiaoxue Zhang, et al.
Published: (2019-01-01) -
ICG fluorescence imaging as a new tool for optimization of pathological evaluation in breast cancer tumors after neoadjuvant chemotherapy.
by: Isabelle Veys, et al.
Published: (2018-01-01) -
Influence of ICG-technology on the results of surgical treatment of early forms of breast cancer
by: J. Masia, et al.
Published: (2021-06-01) -
Technique of ICG-guided Targeted Compartmental Pelvic Lymphadenectomy (TCL) combined with Pelvic Peritoneal Mesometrial Resection (PMMR) for locoregional control of endometrial cancer – A proposal
by: Rainer Kimmig, et al.
Published: (2017-05-01) -
Use of indocyanine green (ICG) in detection of axillary sentinel lymph nodes for breast cancer
by: C. Nikolaou
Published: (2021-04-01)